Psomagen Inc.

04/30/2026

There’s nothing better than turning a frustrating experience into a successful one! At Psomagen, we’re committed to delivering:

- Fast, dependable sequencing
- High-quality read data you can trust
- Responsive customer care every step of the way
- Pricing that works with your budget

Because your research deserves a partner that gets it right.
Explore our services today: https://hubs.ly/Q04dmrwS0

04/27/2026

The word is out! Macrogen and Psomagen are adding the new 10x Genomics Atera spatial platform to our labs around the world. We’re excited to bring this unprecedented single-cell whole transcriptome resolution to our labs — read the full announcement here:

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform...

04/23/2026

Long reads are mapping unexplored territory! In this study: the red flour beetle is frequently used as a model organism for evolutionary and developmental research, including transgenic studies. Researchers from Indiana University mapped the organism’s DNA in relation to the vermillion white (vw) mutation. They identified two additional upstream genetic loci eliminated by this mutation.

Psomagen provided DNA extraction, library construction, and PacBio long-read sequencing for this project.

Read the full paper: https://hubs.ly/Q04cBzk10

04/21/2026

To our NIH followers: Psomagen’s coming to campus this month! Find us at the NIH Spring Show on April 29. We’re excited to talk to you about your next project — meet with:

Lori Mull, Spatial Biology & Proteomics Product Manager
Anokhi Kashiparekh, Regional Sales Manager
Jung Young Park, Revenue Operations Manager

Check out all upcoming events here: https://bit.ly/4sMGozP

04/16/2026

What will you capture? The Cellanome R3200’s AI-assisted cell or ensemble isolation allows you to combine imaging and sequencing for the same exact single cells.

Through June 2026, Psomagen’s labs are subsidizing pilot projects — try out the latest in single-cell innovation at a fraction of the standard cost. Reach out to get on the list: https://bit.ly/3O53P9p

04/15/2026

NEW PAPER: Researchers from the US and China combined their efforts to identify an “integrated germline and somatic genomic model” able to identify a novel 13% of the population that is at high risk for coronary artery disease that polygenic risk score alone completely misses.

This multiomics score was developed by combining genomics with six germline and somatic markers. Testing was done on the UK Biobank data and validation was conducted on TOPMed data. Psomagen is proud to be a contributor of sequencing data for TOPMed projects, including genome sequencing data used in this study. This new model can contribute to the early detection and treatment of those with this previously unknown medical condition, potentially saving lives.

Read the full paper: https://go.nature.com/4sptVli

04/08/2026

The latest from 10x Genomics has landed in our labs! GEM-X Flex v2/Apex technology makes fixed-sample single-cell multiplexing a reality — making large-scale, longitudinal studies more attainable.

See what you can learn with expanded sample types and unprecedented scale: https://bit.ly/4cequIa

04/02/2026

We’re proud to support scientists and researchers in the Autism Spectrum Disorder (ASD) space. This World Autism Day, we're sharing major research publications conducted by our customers with support from our labs.

📙 Splicing and frameshift variants in QSER1 may be involved in developmental phenotypes: https://hubs.ly/Q048ywYd0

📘 Rare variation in non-coding regions with evolutionary signatures contributes to autism spectrum disorder risk: https://hubs.ly/Q048yvcL0

📗 Increased degradation of FMRP contributes to neuronal hyperexcitability in tuberous sclerosis complex: https://hubs.ly/Q048yfhk0

04/01/2026

In case you missed it — Psomagen is offering OmicInsight spatial imaging technology in our labs! This new technology offers co-detection of RNA and protein, with subcellular resolution for large-scale, high-throughput projects.

Learn more when you read the announcement: https://hubs.ly/Q048wtVZ0

03/26/2026

Exciting news! We’re proud to unveil our new integrated assay platform, the Cellanome R3200, uniting imaging-based phenotypic profiling with molecular quantification. This platform offers first-of-its-kind CellCage technology, delivering unmatched insights at single-cell resolution.

Learn how this approach can deepen your single-cell and multi-omics studies, one cell at a time: https://hubs.ly/Q047JL280

03/25/2026

Stop by AACR booth 812 next month to say hi to our team! We’re excited to talk to oncology researchers about your upcoming omics needs. Meet:

Andrew Bolt, SE Regional Account Manager
Mariam Marand, West Regional Account Manager
Noura Darwish, South Regional Account Manager

03/23/2026

Guess what’s in the box! Big things at Psomagen, coming soon 👀 Stay tuned for the reveal later this week…